← FDA DRUG APPROVALS

FDA NDA · NDA010791

RUBIVITE

Sponsor: BEL MAR

APPLICATION
NDA010791
TYPE
NDA
ORIGINAL APPROVAL
1958-07-14
LATEST ACTION
1958-07-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

RUBIVITEDiscontinued
CYANOCOBALAMIN 0.03MG/ML · INJECTABLE · INJECTION
RUBIVITEDiscontinued
CYANOCOBALAMIN 0.1MG/ML · INJECTABLE · INJECTION
RUBIVITEDiscontinued
CYANOCOBALAMIN 0.12MG/ML · INJECTABLE · INJECTION
RUBIVITEDiscontinued
CYANOCOBALAMIN 1MG/ML · INJECTABLE · INJECTION
RUBIVITEDiscontinued
CYANOCOBALAMIN 0.05MG/ML · INJECTABLE · INJECTION

Approval history

1958-07-14Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →